CAS 75443-99-1
:Ácido naftacenecarboxílico, 2-etil-1,2,3,4,6,11-hexahidro-2,5,7-trihidroxi-6,11-dioxo-4-[[2,3,6-trideoxi-4-O-[2,6-dideoxi-4-O-[(2R,6S)-tetrahidro-6-metil-5-oxo-2H-piran-2-il]-α-L-lixo-hexopiranosil]-3-(dimetilamino)-α-L-lixo-hexopiranosil]oxi]-, éster metílico, clorhidrato (1:1), (1R,2R,4S)-
Descripción:
Ácido naftacenecarboxílico, 2-etil-1,2,3,4,6,11-hexahidro-2,5,7-trihidroxi-6,11-dioxo-4-[[2,3,6-trideoxi-4-O-[2,6-dideoxi-4-O-[(2R,6S)-tetrahidro-6-metil-5-oxo-2H-piran-2-il]-α-L-lixo-hexopiranosil]-3-(dimetilamino)-α-L-lixo-hexopiranosil]oxi]-, éster metílico, clorhidrato (1:1), (1R,2R,4S)-, identificado por el número CAS 75443-99-1, es un compuesto orgánico complejo caracterizado por su intrincada estructura molecular, que incluye múltiples grupos funcionales como ácidos carboxílicos, hidroxilos y ésteres. Este compuesto exhibe propiedades típicas de los derivados del naftaleno y estructuras similares a carbohidratos, lo que sugiere una posible actividad biológica. Su forma de clorhidrato indica que es una sal, lo que puede mejorar su solubilidad en soluciones acuosas. La presencia de múltiples estereocentros implica que puede existir en diferentes formas estereoisoméricas, lo que puede influir en su reactividad e interacción con sistemas biológicos. En general, la estructura única de este compuesto puede contribuir a sus posibles aplicaciones en farmacéutica o bioquímica, aunque las actividades biológicas específicas y las aplicaciones requerirían una investigación adicional.
Fórmula:C42H53NO15·ClH
InChI:InChI=1S/C42H53NO15.ClH/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29;/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3;1H/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+;/m0./s1
Clave InChI:InChIKey=KUSMIBXCRZTVML-PCCPLWKKSA-N
SMILES:C(OC)(=O)[C@@H]1C2=C([C@@H](O[C@H]3C[C@H](N(C)C)[C@H](O[C@H]4C[C@H](O)[C@H](O[C@@H]5O[C@@H](C)C(=O)CC5)[C@H](C)O4)[C@H](C)O3)C[C@@]1(CC)O)C(O)=C6C(=C2)C(=O)C=7C(C6=O)=C(O)C=CC7.Cl
Sinónimos:- 1-Naphthacenecarboxylic acid, 1,2,3,4,6,11-hexahydro-6,11-dioxo-2-ethyl-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-2,5,7-trihydroxy-, methyl ester, hydrochloride, (1R-(1-alpha,2-beta,4-beta))-
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-l-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-l-lyxo-hexopyranosyl)oxy)-, methyl ester, hydrochloride, (1R-(1alpha,2beta,4beta))-
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</smallcap>-lyxo-hexopyranosyl]-3-(dimethylamino)-α-<smallcap>L</span>-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride (1:1), (1R,2R,4S)-
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</smallcap>-lyxo-hexopyranosyl]-3-(dimethylamino)-α-<smallcap>L</span>-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride, (1R,2R,4S)-
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</smallcap>-lyxo-hexopyranosyl]-3-(dimethylamino)-α-<smallcap>L</span>-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride, [1R-(1α,2β,4β)]-
- Aclacinomycin A hydrochloride
- Aclacinon
- Aclaplastin
- Aclarubicin HCl
- Aclarubicina clorhidrato
- Aclarubicina clorhidrato [Spanish]
- Unii-501948Ri66
- methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate hydrochloride (1:1)
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride (1:1), (1R,2R,4S)-
- Aclarubicin hydrochloride
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride, (1R,2R,4S)-
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 4 productos.
Aclacinomycin A hydrochloride
CAS:<p>Aclacinomycin A hydrochloride (Aclarubicin HCl) is an antibiotic and inhibitor of topoisomerase I/II, interfering with DNA transcription and replication,</p>Fórmula:C42H54ClNO15Pureza:98%Forma y color:SolidPeso molecular:848.33Aclacinomycin HCl
CAS:<p>Aclacinomycin HCl is a cytotoxic antibiotic that inhibits the growth of tumor cells. It has been shown to induce apoptosis in human leukemia cells by altering the transmembrane potential and inhibiting cell proliferation. Aclacinomycin HCl also induces DNA damage response, which leads to caspase activities and cell death. This drug is highly selective for tumor cells, with no effect on normal cells. It has been shown to be effective against primary liver cancer in animal models, as well as developmental disorders such as autism spectrum disorder (ASD).</p>Fórmula:C42H53NO15·HClPureza:Min. 95%Forma y color:Orange PowderPeso molecular:848.33 g/mol



